Focalyx® is a urologist-founded medtech company that is redefining the treatment path for men with prostate disease. Focalyx Technologies, fully subsidiary of Focalyx® Holding, is a US Medical Device Manufacturer with its headquarters in Miami, Florida.

The Focalyx Fusion system, originally developed by the University College of London (UCL), was acquired by Focalyx Technologies in November 2019.  Focalyx Technologies has added in the development of the device since then.